Matches in Wikidata for { <http://www.wikidata.org/entity/Q67126153> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q67126153 description "clinical trial" @default.
- Q67126153 description "ensayu clínicu" @default.
- Q67126153 description "klinisch onderzoek" @default.
- Q67126153 description "клінічне випробування" @default.
- Q67126153 description "կլինիկական փորձարկում" @default.
- Q67126153 name "Clinical Study to Explore the Effects of Actelion's Latest Endothelin Receptor Antagonist (ERA) - at Different Dose Strengths - on the Efficacy, Safety and Tolerability in Subjects With Essential Hypertension" @default.
- Q67126153 name "Clinical Study to Explore the Effects of Actelion's Latest Endothelin Receptor Antagonist (ERA) - at Different Dose Strengths - on the Efficacy, Safety and Tolerability in Subjects With Essential Hypertension" @default.
- Q67126153 type Item @default.
- Q67126153 label "Clinical Study to Explore the Effects of Actelion's Latest Endothelin Receptor Antagonist (ERA) - at Different Dose Strengths - on the Efficacy, Safety and Tolerability in Subjects With Essential Hypertension" @default.
- Q67126153 label "Clinical Study to Explore the Effects of Actelion's Latest Endothelin Receptor Antagonist (ERA) - at Different Dose Strengths - on the Efficacy, Safety and Tolerability in Subjects With Essential Hypertension" @default.
- Q67126153 prefLabel "Clinical Study to Explore the Effects of Actelion's Latest Endothelin Receptor Antagonist (ERA) - at Different Dose Strengths - on the Efficacy, Safety and Tolerability in Subjects With Essential Hypertension" @default.
- Q67126153 prefLabel "Clinical Study to Explore the Effects of Actelion's Latest Endothelin Receptor Antagonist (ERA) - at Different Dose Strengths - on the Efficacy, Safety and Tolerability in Subjects With Essential Hypertension" @default.
- Q67126153 P1050 Q67126153-5EFBFD19-2808-46FF-BC8B-AF457E9545D3 @default.
- Q67126153 P1050 Q67126153-644455A2-FC18-44BF-A895-58F1F5F7FE7D @default.
- Q67126153 P1132 Q67126153-A1CC069F-2E4B-42EE-8E86-E18A4F798FBC @default.
- Q67126153 P1476 Q67126153-F20EFA5B-BC36-4370-B473-8721C2FD7449 @default.
- Q67126153 P17 Q67126153-2F813F7A-927F-443C-99F0-79CA29F953A7 @default.
- Q67126153 P17 Q67126153-AA49382F-62DC-41FB-A272-0295A274AF45 @default.
- Q67126153 P17 Q67126153-DDBD2BFA-9DE3-4C5E-9A15-E31BD1FDC4FC @default.
- Q67126153 P17 Q67126153-F187E5BF-B8EB-420E-BB76-87E712AD597B @default.
- Q67126153 P2899 Q67126153-CA175748-CBBF-407D-887A-7BA5074727BC @default.
- Q67126153 P3098 Q67126153-A67A80F7-8CD2-41C9-B9AF-28478295F4C2 @default.
- Q67126153 P31 Q67126153-13E1A340-789F-4113-A0C0-D32CE17CE7F8 @default.
- Q67126153 P4135 Q67126153-139A0999-12DF-4E18-B471-B40016A16FD5 @default.
- Q67126153 P580 Q67126153-B58EC40E-2205-437F-9638-40925DD0684A @default.
- Q67126153 P582 Q67126153-8B1E9223-1C47-4579-8150-11FED9B74B89 @default.
- Q67126153 P6099 Q67126153-E33C163B-74B8-421A-8FC7-C1861ED7D8ED @default.
- Q67126153 P8363 Q67126153-385F10E6-E2F3-4C55-8A6B-8C0F275B48B9 @default.
- Q67126153 P1050 Q41861 @default.
- Q67126153 P1050 Q988405 @default.
- Q67126153 P1132 "+996" @default.
- Q67126153 P1476 "Multi-center, Double-blind, Double-dummy, Randomized, Placebo- and Active-reference, Parallel Group, Phase 2 Dose-finding Study With Actelion's Latest Endothelin Receptor Antagonist (ERA) in Subjects With Essential Hypertension (Grade 1 and 2)" @default.
- Q67126153 P17 Q1183 @default.
- Q67126153 P17 Q16 @default.
- Q67126153 P17 Q30 @default.
- Q67126153 P17 Q801 @default.
- Q67126153 P2899 "+18" @default.
- Q67126153 P3098 "NCT02603809" @default.
- Q67126153 P31 Q30612 @default.
- Q67126153 P4135 "+75" @default.
- Q67126153 P580 "2016-01-25T00:00:00Z" @default.
- Q67126153 P582 "2017-03-31T00:00:00Z" @default.
- Q67126153 P6099 Q42824440 @default.
- Q67126153 P8363 Q78089383 @default.